Loading…
Lobbying Income
$25.4M
Filings
869
Unique Clients
23
Active Period
2007–2025
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Ensuring Community Access to Pharmacist Services Act
2025 · fourth_quarter · Client: CENCORA FKA AMERISOURCEBERGEN CORPORATION
HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician Fee Schedule Proposed Rule
Client expense: — · Firm income: $50,000
Matched citations: H.R. 3164
Keep Every Extra Penny Act of 2025
2025 · fourth_quarter · Client: CENCORA FKA AMERISOURCEBERGEN CORPORATION
HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician Fee Schedule Proposed Rule
Client expense: — · Firm income: $50,000
Matched citations: HR 405
Community Investment and Prosperity Act
2025 · fourth_quarter · Client: CENCORA FKA AMERISOURCEBERGEN CORPORATION
HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician Fee Schedule Proposed Rule
Client expense: — · Firm income: $50,000
Matched citations: S. 2464
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · fourth_quarter · Client: PHRMA
340B issues, Medicare Part D, Medicare Part B Issues, Importation of Drugs, Drug Pricing, Inflation Reduction Act, Insurance coverage issues related to prescription drugs; H.R. 1, the One Big Beautiful Bill Act; H.R. 1492, S. 832, the EPIC Act; Most Favored Nation Drug Pricing; Medicare IRA implementation, Drug Premium Stabilization Program.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2025 · fourth_quarter · Client: PHRMA
340B issues, Medicare Part D, Medicare Part B Issues, Importation of Drugs, Drug Pricing, Inflation Reduction Act, Insurance coverage issues related to prescription drugs; H.R. 1, the One Big Beautiful Bill Act; H.R. 1492, S. 832, the EPIC Act; Most Favored Nation Drug Pricing; Medicare IRA implementation, Drug Premium Stabilization Program.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1492
340B issues, Medicare Part D, Medicare Part B Issues, Importation of Drugs, Drug Pricing, Inflation Reduction Act, Insurance coverage issues related to prescription drugs; H.R. 1, the One Big Beautiful Bill Act; H.R. 1492, S. 832, the EPIC Act; Most Favored Nation Drug Pricing; Medicare IRA implementation, Drug Premium Stabilization Program.
Client expense: — · Firm income: $50,000
Matched citations: S. 832
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Client: PHRMA
340B issues, Medicare Part D, Medicare Part B Issues, Importation of Drugs, Drug Pricing, Inflation Reduction Act, Insurance coverage issues related to prescription drugs; H.R. 1, the One Big Beautiful Bill Act; H.R. 1492, S. 832, the EPIC Act; Most Favored Nation Drug Pricing; Medicare IRA implementation, Drug Premium Stabilization Program.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2025 · third_quarter · Client: PHRMA
340B issues, Medicare Part D, Medicare Part B Issues, Importation of Drugs, Drug Pricing, Inflation Reduction Act, Insurance coverage issues related to prescription drugs; H.R. 1, the One Big Beautiful Bill Act; H.R. 1492, S. 832, the EPIC Act; Most Favored Nation Drug Pricing; Medicare IRA implementation, Drug Premium Stabilization Program.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1492
340B issues, Medicare Part D, Medicare Part B Issues, Importation of Drugs, Drug Pricing, Inflation Reduction Act, Insurance coverage issues related to prescription drugs; H.R. 1, the One Big Beautiful Bill Act; H.R. 1492, S. 832, the EPIC Act; Most Favored Nation Drug Pricing; Medicare IRA implementation, Drug Premium Stabilization Program.
Client expense: — · Firm income: $50,000
Matched citations: S. 832
Ensuring Community Access to Pharmacist Services Act
2025 · third_quarter · Client: CENCORA FKA AMERISOURCEBERGEN CORPORATION
HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician Fee Schedule Proposed Rule
Client expense: — · Firm income: $50,000
Matched citations: H.R. 3164
Keep Every Extra Penny Act of 2025
2025 · third_quarter · Client: CENCORA FKA AMERISOURCEBERGEN CORPORATION
HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician Fee Schedule Proposed Rule
Client expense: — · Firm income: $50,000
Matched citations: HR 405
Community Investment and Prosperity Act
2025 · third_quarter · Client: CENCORA FKA AMERISOURCEBERGEN CORPORATION
HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician Fee Schedule Proposed Rule
Client expense: — · Firm income: $50,000
Matched citations: S. 2464
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Client: PHRMA
340B issues, Medicare Part D, Medicare Part B Issues, Importation of Drugs, Drug Pricing, Inflation Reduction Act, Insurance coverage issues related to prescription drugs; H.R. 1, the One Big Beautiful Bill Act; H.R. 1492, S. 832, the EPIC Act; Most Favored Nation Drug Pricing; Medicare IRA implementation, Drug Premium Stabilization Program.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2025 · second_quarter · Client: PHRMA
340B issues, Medicare Part D, Medicare Part B Issues, Importation of Drugs, Drug Pricing, Inflation Reduction Act, Insurance coverage issues related to prescription drugs; H.R. 1, the One Big Beautiful Bill Act; H.R. 1492, S. 832, the EPIC Act; Most Favored Nation Drug Pricing; Medicare IRA implementation, Drug Premium Stabilization Program.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1492
340B issues, Medicare Part D, Medicare Part B Issues, Importation of Drugs, Drug Pricing, Inflation Reduction Act, Insurance coverage issues related to prescription drugs; H.R. 1, the One Big Beautiful Bill Act; H.R. 1492, S. 832, the EPIC Act; Most Favored Nation Drug Pricing; Medicare IRA implementation, Drug Premium Stabilization Program.
Client expense: — · Firm income: $50,000
Matched citations: S. 832
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Client: CENCORA FKA AMERISOURCEBERGEN CORPORATION
Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; Act; Seniors' Access to Critical Medications Act (H.R. 2484); HR1, the One Big Beautiful Bill Act; HHS - drug pricing issues, implementation of Inflation Reduction Act.
Client expense: — · Firm income: $50,000
Matched citations: HR1
Seniors’ Access to Critical Medications Act of 2025
2025 · second_quarter · Client: CENCORA FKA AMERISOURCEBERGEN CORPORATION
Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; Act; Seniors' Access to Critical Medications Act (H.R. 2484); HR1, the One Big Beautiful Bill Act; HHS - drug pricing issues, implementation of Inflation Reduction Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2484
Keep Every Extra Penny Act of 2025
2025 · second_quarter · Client: CENCORA FKA AMERISOURCEBERGEN CORPORATION
Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; Act; Seniors' Access to Critical Medications Act (H.R. 2484); HR1, the One Big Beautiful Bill Act; HHS - drug pricing issues, implementation of Inflation Reduction Act.
Client expense: — · Firm income: $50,000
Matched citations: HR 405
Telehealth Modernization Act of 2024
2025 · first_quarter · Client: HEALTH INNOVATION ALLIANCE
Issues related to health data privacy and security, patient access to data, real-time benefit tools, and clinical decision support software, including the American Privacy Rights Act; Issues related to health data interoperability, standards, information blocking, and the access, exchange, and use of health data; access to and coverage of telehealth services, including mental and behavioral health services, broadband access and infrastructure development, including the Telehealth Modernization Act (H.R. 7623); Issues related to the use of artificial intelligence in health care.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7623
Lower Costs, More Transparency Act
2025 · first_quarter · Client: CENCORA FKA AMERISOURCEBERGEN CORPORATION
Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; HR 5378-Lower Costs, More Transparency Act; S.2973-Modernizing and Ensuring PBM Accountability Act; HR 5526-Seniors'Access to Critical Medications Act of 2023; S.2764 and HR 5391, the Protecting Patient Access to Cancer and Complex Therapies Act, Seniors Access to Critical Medications Act (H.R. 5526).
Client expense: — · Firm income: $50,000
Matched citations: HR 5378
Protecting Patient Access to Cancer and Complex Therapies Act
2025 · first_quarter · Client: CENCORA FKA AMERISOURCEBERGEN CORPORATION
Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; HR 5378-Lower Costs, More Transparency Act; S.2973-Modernizing and Ensuring PBM Accountability Act; HR 5526-Seniors'Access to Critical Medications Act of 2023; S.2764 and HR 5391, the Protecting Patient Access to Cancer and Complex Therapies Act, Seniors Access to Critical Medications Act (H.R. 5526).
Client expense: — · Firm income: $50,000
Matched citations: HR 5391
Seniors’ Access to Critical Medications Act of 2024
2025 · first_quarter · Client: CENCORA FKA AMERISOURCEBERGEN CORPORATION
Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; HR 5378-Lower Costs, More Transparency Act; S.2973-Modernizing and Ensuring PBM Accountability Act; HR 5526-Seniors'Access to Critical Medications Act of 2023; S.2764 and HR 5391, the Protecting Patient Access to Cancer and Complex Therapies Act, Seniors Access to Critical Medications Act (H.R. 5526).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5526, HR 5526
Keep Every Extra Penny Act of 2025
2025 · first_quarter · Client: CENCORA FKA AMERISOURCEBERGEN CORPORATION
Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; HR 5378-Lower Costs, More Transparency Act; S.2973-Modernizing and Ensuring PBM Accountability Act; HR 5526-Seniors'Access to Critical Medications Act of 2023; S.2764 and HR 5391, the Protecting Patient Access to Cancer and Complex Therapies Act, Seniors Access to Critical Medications Act (H.R. 5526).
Client expense: — · Firm income: $50,000
Matched citations: HR 405
Protecting Patient Access to Cancer and Complex Therapies Act of 2023
2025 · first_quarter · Client: CENCORA FKA AMERISOURCEBERGEN CORPORATION
Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; HR 5378-Lower Costs, More Transparency Act; S.2973-Modernizing and Ensuring PBM Accountability Act; HR 5526-Seniors'Access to Critical Medications Act of 2023; S.2764 and HR 5391, the Protecting Patient Access to Cancer and Complex Therapies Act, Seniors Access to Critical Medications Act (H.R. 5526).
Client expense: — · Firm income: $50,000
Matched citations: S.2764
Modernizing and Ensuring PBM Accountability Act
2025 · first_quarter · Client: CENCORA FKA AMERISOURCEBERGEN CORPORATION
Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; HR 5378-Lower Costs, More Transparency Act; S.2973-Modernizing and Ensuring PBM Accountability Act; HR 5526-Seniors'Access to Critical Medications Act of 2023; S.2764 and HR 5391, the Protecting Patient Access to Cancer and Complex Therapies Act, Seniors Access to Critical Medications Act (H.R. 5526).
Client expense: — · Firm income: $50,000
Matched citations: S.2973
Source: Senate LDA